Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Asx5.0
Astaxanthin – Forschung
Hilft wahrscheinlich
71 begutachtete Studien
Was die Evidenz sagt
Hilft wahrscheinlich
Astaxanthin scheint in 5 von 7 Studien mit messbaren Effekten zu helfen — die Evidenz tendiert klar ins Positive.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 2018–2026 mit einer typischen Studiengröße von 53 Teilnehmenden.
Basierend auf 71 Studien · 13 Meta-Analysen · 18 RCTs · 9,079 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
5geholfen1unklar1nicht geholfen· 64 weitere ohne bewertete Effektdaten
Nach Outcome
Inflammation & oxidative stressSenkt leicht die Marker für oxidativen Stress; klinischer entzündungshemmender Nutzen nicht belegt · 4-8 weeks
Hilft wahrscheinlich18 Studien
Glucose & metabolic
Überwiegend Mechanismus / Beobachtung9 Studien
Neuroprotection & brain aging
Überwiegend Mechanismus / Beobachtung9 Studien
Women's health
Überwiegend Mechanismus / Beobachtung8 Studien
Cognitive function
Überwiegend Mechanismus / Beobachtung7 Studien
Heart & blood pressureKardiovaskulärer Nutzen nicht gut belegt; nur auf Biomarker-Ebene · 8-12 weeks
Überwiegend Mechanismus / Beobachtung6 Studien
Skin healthVerbesserte Hautfeuchtigkeit und Hautstruktur in RCTs · 6-12 weeks · Verringertes Erscheinungsbild von Falten in kleinen RCTs · 6-12 weeks · Verbesserte Hautelastizität · 6-12 weeks · Geringe Vorteile bei der Hautalterung (Feuchtigkeit, Elastizität, UV) in überwiegend kleinen, von der Industrie finanzierten Studien · 6-12 weeks
Überwiegend Mechanismus / Beobachtung6 Studien
RecoveryKann Marker für oxidativen Stress senken; Nutzen für die Regeneration nicht nachgewiesen · 2-4 weeks
Überwiegend Mechanismus / Beobachtung4 Studien
Cholesterol & lipidsKardiovaskulärer Nutzen nicht gut belegt; nur auf Biomarker-Ebene · 8-12 weeks
Überwiegend Mechanismus / Beobachtung4 Studien
Endurance & exercise performanceNutzen für die Ausdauer in der aktuellen Evidenz nicht belegt · 4-8 weeks
Vision & eye healthNutzen bei Augenmüdigkeit durch die aktuelle Evidenz nicht gestützt · 4-8 weeks
Zu wenige bewertete Studien1 Studie
Therapeutic & clinical
Zu wenige bewertete Studien1 Studie
Longevity & aging
Zu wenige bewertete Studien1 Studie
Safety profile
Zu wenige bewertete Studien1 Studie
In Zahlen
Aus 42 Studien mit messbaren Effekten gezogen
Wahrscheinlich echte Effekte
89%
über Studien hinweg
Untersuchte Personen
9,079
typische Studie: 53 Personen
Stärkste Designs
31
13 gepoolt, 18 randomisiert
Zeigte Nutzen
71%
5/7 Studien
Wie lange Studien liefen
1–4 Wochen
1
1–3 Monate
4
3+ Monate
1
Untersuchte Populationen
General population2
Adults including T2DM patients1
Women undergoing fertility treatment1
Human subjects1
Aktives Forschungsgebiet
70 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2026
20182026
1Blood malondialdehyde concentrationMeta-AnalyseCited 25×n=380 · medium study2022
Compared with placebo, astaxanthin significantly reduced blood malondialdehyde concentration (standardized mean difference [SMD]: -0.95; 95% CI, -1.67 to -0.23; P = .01).
Ma B et al. · Nutrition research (New York, N.Y.) (2022)
Sehr groß Nutzen
← SchlechterKein EffektBesser →
Likely real
Compared with placebo, astaxanthin significantly reduced blood malondialdehyde concentration (standardized mean difference [SMD]: -0.95; 95% CI, -1.67 to -0.23; P = .01).
The lowering effect of astaxanthin supplementation on malondialdehyde was particularly significant in type 2 diabetes mellitus (T2DM) patients (SMD: -0.64; 95% CI, -1.26 to -0.01; P < .05).
Astaxanthin significantly reduced blood interleukin-6 concentration in T2DM patients (weighted mean difference: -0.70 pg/mL; 95% CI, -1.29 to -0.11 pg/mL; P = .02).
This systematic review shows that AST supplementation may improve assisted reproductive technology outcomes by enhancing oocyte quality and reducing OS in the reproductive organs.
Maleki-Hajiagha A et al. · Journal of ovarian research (2024)
This systematic review shows that AST supplementation may improve assisted reproductive technology outcomes by enhancing oocyte quality and reducing OS in the reproductive organs.
However, the evidence is limited by the heterogeneity, risk of bias, and small sample size of the included studies.
Ingestion and/or topical usages of ASX may be effective in reducing skin ageing and have promising cosmetical potential, as it improves moisture content and elasticity and reduces wrinkles.
Zhou X et al. · Nutrients (2021)
Ingestion and/or topical usages of ASX may be effective in reducing skin ageing and have promising cosmetical potential, as it improves moisture content and elasticity and reduces wrinkles.
4Skin health improvementSystematische ÜbersichtCited 26×2021
Overall, there is some clinical data to support the benefits of astaxanthin supplementation (in the range of 3 to 6 mg/d) on skin health, especially for photoaged skin.
Ng QX et al. · Journal of dietary supplements (2021)
However, most available studies had a relatively small sample size and were conducted on healthy Japanese females.
Many of the studies were also funded by commercial entities, with potential conflicts of interests.
This was difficult to account for in our analyses.
Further well-designed clinical trials are needed to confirm optimal dosing and mechanisms of action.
Malcangi G et al. · International journal of molecular sciences (2026)
In women with Polycystic Ovary Syndrome (PCOS) or endometriosis, ASX downregulated endoplasmic reticulum stress-related apoptotic pathways and improved oocyte and embryo quality.
Cardiometabolic and respiratory outcomes showed improved endothelial function and reduced disease severity.
Astaxanthin demonstrates broad antioxidant and anti-inflammatory properties, supporting its role as a promising adjunctive therapy for metabolic, reproductive, and cardiovascular health.
7Liver enzyme levels (ALT, AST, GGT)Meta-Analysen=757 · large study2025
Carotenoid supplementation might be beneficial in reducing liver enzymes, especially in non-healthy participants and in those with a BMI ≥ 25 kg/m2.
Heydari SS et al. · BMC complementary medicine and therapies (2025)
Likely real
Significant reductions in ALT levels occurred in < 12 weeks (P = 0.028), BMI ≥ 25 (P = 0.045), and among non-healthy participants (P = 0.015).
AST levels were significantly reduced in non-healthy participants (P = 0.003) with ages > 50 (P = 0.003) as well as GGT levels (P = 0.011) in non-healthy participants.
Carotenoid supplementation might be beneficial in reducing liver enzymes, especially in non-healthy participants and in those with a BMI ≥ 25 kg/m2.
8Prevention of idiopathic Parkinson's diseaseSystematische Übersicht2025
Answering this will require further research.
Huenchuguala S et al. · Nutrients (2025)
This repeated failure is likely because these studies ignore the extremely slow neurodegenerative process, which unfolds over many years.
Importantly, specific bioactive compounds from food can activate this pathway, increasing the production of these protective enzymes.
For instance, the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), along with astaxanthin-a compound present in cold-water fish like salmon-have been demonstrated to enhance enzyme expression.
Long-term RCTs are needed to corroborate risk-benefit ratios across different antioxidant functional lipid supplementation settings.
Wan S et al. · Nutrients (2024)
The benefits of antioxidant lipid supplementations appeared to be most evident in blood pressure and blood lipids in participants with different cardiometabolic health statuses.
Notably, n9 fatty acid increased triglyceride and hemoglobin A1C in the total population, which increases CVD risk.
Antioxidant lipid supplementations ameliorate cardiometabolic risk factors, while their effect may depend on type and cardiometabolic health status.
The review then concludes with the potential additive effects that astaxanthin may offer in conjunction with endurance training for the endurance athlete and offers some suggested practical recommendations for athletes and coaches interested in supplementing with astaxanthin.
Waldman H · Nutrients (2024)
Originally used in fish feed, astaxanthin has shown a greater ability to mitigate various reactive oxygen species and maintain the structural integrity of mitochondria compared to other exogenous antioxidants.
The review then concludes with the potential additive effects that astaxanthin may offer in conjunction with endurance training for the endurance athlete and offers some suggested practical recommendations for athletes and coaches interested in supplementing with astaxanthin.
12Cognitive function and neurodegenerationSystematische Übersicht2024
Key findings include the positive impacts of astaxanthin in relation to improving cognitive function, facilitating neuroprotection, and slowing neurodegeneration within given contexts.
Queen CJJ et al. · Nutrients (2024)
Given the aforementioned promising effects, research into astaxanthin with a focus on cognitive function has recently been extended to human tissue and human populations.
The present critical review explores the effects of astaxanthin on cognitive function and neurodegeneration within human populations and samples with the aim of deciphering the merit and credibility of the research findings and subsequently their potential as a basis for therapeutic use.
Implications, limitations, and areas for future research development are also discussed.
Therefore, astaxanthin is worthy of further investigation for boosting human health, and wide applications in the food industry.
Cao Y et al. · Critical reviews in food science and nutrition (2023)
Gut microbiota may involve the fate of astaxanthin during digestion and absorption; thus, further knowledge is needed to establish accurate recommendations for dietary intake of both healthy and special populations.
Additionally, preclinical trials predict its potential effects such as intestinal flora regulation and anti-diabetic activity.
Therefore, astaxanthin is worthy of further investigation for boosting human health, and wide applications in the food industry.
14astaxanthin's protective effects against age-related diseasesSystematische Übersicht2023
We have also briefly discussed astaxanthin's protective effects on reproductive health.
Alugoju P et al. · Critical reviews in food science and nutrition (2023)
The natural dietary antioxidant supplementation offers substantial pharmacological and therapeutic effects against various disease conditions.
Astaxanthin is one such natural carotenoid with superior antioxidant activity than other carotenoids, as well as well as vitamins C and E, and additionally, it is known to exhibit a plethora of pharmacological effects.
We have also briefly discussed astaxanthin's protective effects on reproductive health.
However, more studies, including clinical trials, are needed to determine the influence of AST on miRNAs associated with CVDs.
Chaboksafar M et al. · International journal of food sciences and nutrition (2022)
In vivo articles revealed that AST increased the expression of miR-124, miR-7, miR-29a-3p, and miR-200a but decreased miR-21 and miR-31-5p and the only clinical study showed a drop in miR-146a.
The findings indicate that AST regulated different pathways of miRNAs implicated in various conditions.
Therefore AST as a new therapeutic strategy could be essential in preventing and controlling CVDs.
16Bone density and structureSystematische Übersicht2022
Concurrent supplementation with taurine, N-acetylcysteine, vitamins D and K2, and minerals, including magnesium, zinc, and manganese, plus a diet naturally high in potassium, may also be helpful in this regard.
McCarty MF et al. · International journal of molecular sciences (2022)
Additionally, certain flavonols, notably quercetin, can inhibit CK2 in high nanomolar concentrations that may be clinically relevant.
Many, though not all, of these agents have shown favorable effects on bone density and structure in rodent models of bone loss.
Complex nutraceutical regimens providing a selection of these nutraceuticals in clinically meaningful doses may have an important potential for preserving bone health.
17Inflammatory biomarkersMeta-Analysen=26 · very small study2022
The overall results supported possible protective effects of carotenoids on inflammatory biomarkers.
Hajizadeh-Sharafabad F et al. · Critical reviews in food science and nutrition (2022)
Spürbar Nutzen
← SchlechterKein EffektBesser →
Likely real
The random-effect model was used to analyze data and the overall effect size was computed as weighted mean difference (WMD) and corresponding 95% of confidence interval (CI).
A total of 26 trials with 35 effect sizes were included in this meta-analysis.
For the individual carotenoids, astaxanthin, (WMD: ‒0.30 mg/L, 95% CI: ‒0.51, ‒0.09, P = 0.005), lutein/zeaxanthin (WMD: ‒0.30 mg/L, 95% CI: ‒0.45, ‒0.15, P < 0.001), and β-cryptoxanthin (WMD: ‒0.35 mg/L, 95% CI: ‒0.54, ‒0.15, P < 0.001) significantly decreased CRP level.
19UV-induced skin deteriorationRCTCited 87×n=23 · very small study2018
Astaxanthin seems protective against UV-induced skin deterioration and helps maintain healthy skin in healthy people.
Ito N et al. · Nutrients (2018)
Subjective skin conditions for “improvement of rough skin” and “texture” in non-irradiated areas were significantly improved by astaxanthin.
The astaxanthin group showed increased MED compared with placebo.
In addition, the astaxanthin group had a reduced loss of skin moisture in the irradiated area compared with placebo.
20Inflammation and oxidative stress in endometriosisRCTCited 42×n=50 · small study2023
AST pretreatment can modulate inflammation and OS in endometriosis-induced infertile patients.
Rostami S et al. · Frontiers in endocrinology (2023)
Likely real
Increased serum levels of TAC (398.661 ± 57.686 vs. 364.746 ± 51.569; P = 0.004) and SOD (13.458 ± 7.276 vs. 9.040 ± 5.155; P = 0.010) were observed after AST therapy in the treatment group.
Furthermore, serum MDA (14.619 ± 2.505 vs. 15.939 ± 1.512; P = 0.031) decreased significantly following antioxidant treatment.
In addition, significantly lower serum levels of IL-1β (4.515 ± 0.907 vs. 6.8760 ± 0.8478; P = 0.000), IL-6 (5.516 ± 0.646 vs. 5.0543 ± 0.709; P = 0.024) and TNF-α (2.520 ± 0.525 vs. 2.968 ± 0.548; P = 0.038) were observed after AST treatment.